HDFC Mutual Fund Boosts Stake in Global Health with ₹130 Crore Deal

HDFC Mutual Fund has further strengthened its position in the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the operator of the renowned Medanta hospital chain. This latest move marks a significant repeat of the fund's investment strategy following a similar transaction conducted just last month.

Strategic Increase in Stake via Open Market

In a significant block deal executed on the BSE, HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. The total value of this specific transaction amounts to ₹130 crore, representing a 0.37 per cent stake in the company.

The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals. This transaction follows closely on the heels of another deal last month, where HDFC Mutual Fund acquired 10 lakh shares from Sachdeva for over ₹122 crore. As of the end of the March quarter, Sachdeva held a substantial 2.90 crore equity shares, accounting for a 10.79 per cent stake in the healthcare major.

Robust Financial Performance Drives Investor Interest

The increased interest from institutional investors like HDFC Mutual Fund comes amidst a period of impressive financial growth for Global Health. The company has demonstrated strong momentum in its bottom line and top-line figures, signaling healthy operational scaling.

For the fourth quarter ended March 31, 2026, Global Health reported a massive 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore. This is a significant jump from the ₹101.4 crore PAT recorded in the same quarter of the previous fiscal year. Additionally, the company's revenue from operations witnessed a sharp rise to ₹1,159 crore, up from ₹931.3 crore in the corresponding period last year.

Market Reaction and Institutional Confidence

Despite the high-value transaction and strong quarterly results, the stock market showed slight volatility. Shares of Global Health closed at ₹1,311.35 apiece on the BSE, experiencing a minor dip of 0.41 per cent.

However, the repeated accumulation of shares by HDFC Mutual Fund suggests a long-term bullish sentiment regarding the Medanta brand's ability to maintain its growth trajectory in India's competitive healthcare landscape. The fund's willingness to deploy capital at the ₹1,300 price point highlights institutional confidence in the company's valuation and future earnings potential.

Key Takeaways

  • Repeat Investment: HDFC Mutual Fund has purchased an additional 10 lakh shares of Global Health for ₹130 crore, following a similar deal last month.
  • Strong Financial Growth: Global Health reported a 39.7% increase in Q4 PAT to ₹141.7 crore and a significant rise in operational revenue to ₹1,159 crore.
  • Strategic Exit/Dilution: The shares were acquired from co-founder Sunil Sachdeva, who continues to hold a significant 10.79% stake in the company.